Reflect Scientific Inc Receives Order for B-90 Plasma Freezer, Continues to Expand Clientele
OREM, Utah, June 28, 2023 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (OTCQB: RSCF), a leading…
OREM, Utah, June 28, 2023 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (OTCQB: RSCF), a leading…
SAN DIEGO, June 28, 2023 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., or Ambrx (or the…
SAN DIEGO, June 28, 2023 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., or Ambrx (or the…
BOSTON, June 28, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
BOSTON, June 28, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
SAN DIEGO, June 28, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
Former Awardee and Artelo Employee, Professor Saoirse O’Sullivan will Present the 2023 Recipient with the…
SAN DIEGO, June 28, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
Former Awardee and Artelo Employee, Professor Saoirse O’Sullivan will Present the 2023 Recipient with the…
Primary Endpoint of Safety and Efficacy Endpoint Both Met with Clinical Activity and Increased Survival…
Primary Endpoint of Safety and Efficacy Endpoint Both Met with Clinical Activity and Increased Survival…
Company intends to submit 510(k) pre-market notification to the FDA NEW YORK, June 28, 2023…
Company intends to submit 510(k) pre-market notification to the FDA NEW YORK, June 28, 2023…
MINNEAPOLIS, June 28, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage…
MINNEAPOLIS, June 28, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage…
Dr. Zhong Zhong joins Ovid as Chief Scientific Officer (CSO) and Dr. Manoj Malhotra assumes…
Dr. Zhong Zhong joins Ovid as Chief Scientific Officer (CSO) and Dr. Manoj Malhotra assumes…
Results support comparability of cosibelimab 800 mg every-two-week and 1200 mg every-three-week dosing regimens Biologics…
Results support comparability of cosibelimab 800 mg every-two-week and 1200 mg every-three-week dosing regimens Biologics…
SYDNEY, Australia, June 28, 2023 (GLOBE NEWSWIRE) — Recce Pharmaceuticals Limited (ASX: RCE, FSE: R9Q),…